Physician profile
Kelley H Chen
NPI 1124551338
$13,865.44
in general payments reported to CMS, 2019-2025
23 companies · $1,206 in 2025
The $1,206 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $21.96 · 2021: $895 · 2022: $674 · 2023: $8,438 · 2024: $2,631 · 2025: $1,206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,800 · Grant: $4,000 · Travel and Lodging: $3,137 · Education: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,799.91 |
| Grant | $4,000.00 |
| Travel and Lodging | $3,136.90 |
| Education | $337.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,658.47 | 2023 | Corevalve Evolut R, Onyx Frontier |
| Edwards Lifesciences Corporation | $4,380.15 | 2020-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $861.75 | 2021-2025 | Stingray, Avvigo Guidance System |
| Abbott Laboratories | $582.70 | 2021-2025 | Optis, Amplatzer Amulet, Amplatzer |
| Abiomed | $574.30 | 2021-2025 | Impella |
| Inari Medical, INC. | $373.47 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $299.24 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $216.50 | 2021-2022 | |
| Philips North America LLC | $147.19 | 2024 | (6574) Coronary Other |
| Chiesi USA, INC. | $123.98 | 2023 | Kengreal |
| Penumbra, INC. | $116.58 | 2022 | |
| W. L. Gore & Associates, INC. | $98.10 | 2023 | Gore Cardioform Septal Occluder |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.69 | 2021 | |
| Cardiva Medical, INC. | $67.88 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Angiodynamics, INC. | $42.77 | 2023-2024 | Alphavac |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $41.73 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Asahi Intecc USA, INC. | $38.41 | 2024 | Peripheral Vascular |
| Becton, Dickinson and Company | $37.55 | 2025 | True Flow |
| Pfizer INC. | $33.78 | 2024 | |
| Cordis US Corp. | $26.51 | 2025 | Mynx Control Venous |
| Astrazeneca Pharmaceuticals LP | $21.12 | 2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $21.12 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $15.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.